Jiangying Kuang

1.1k total citations
31 papers, 689 citations indexed

About

Jiangying Kuang is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Jiangying Kuang has authored 31 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Physiology and 8 papers in Surgery. Recurrent topics in Jiangying Kuang's work include Adipose Tissue and Metabolism (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Jiangying Kuang is often cited by papers focused on Adipose Tissue and Metabolism (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Jiangying Kuang collaborates with scholars based in China, United States and Bangladesh. Jiangying Kuang's co-authors include Jinhan He, Yanping Li, Qinhui Liu, Shiyun Pu, Shihai Cheng, Jing Shen, Wei Jiang, Qin Tang, Jinhang Zhang and Lei Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Jiangying Kuang

31 papers receiving 684 citations

Peers

Jiangying Kuang

PHYSI

EPIDE

SURGE

Leonor Rivera Spain

Judit Cseh Hungary

Sattar Gorgani‐Firuzjaee Iran

Dafa Ding China

Márton Mohás Hungary

Yuanzhu Huang China

Nengzhi Pang China

Ákos Mérei Hungary

Pál Brasnyó Hungary

Leonor Rivera Spain

Jiangying Kuang

363 ×1.5

PHYSI

187 ×0.8

271 ×1.5

EPIDE

237 ×1.5

60 ×0.8

SURGE

Citations per year, relative to Jiangying Kuang Jiangying Kuang (= 1×) peers Leonor Rivera

Countries citing papers authored by Jiangying Kuang

Since Specialization

Citations

This map shows the geographic impact of Jiangying Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangying Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangying Kuang more than expected).

Fields of papers citing papers by Jiangying Kuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangying Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangying Kuang. The network helps show where Jiangying Kuang may publish in the future.

Co-authorship network of co-authors of Jiangying Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangying Kuang. A scholar is included among the top collaborators of Jiangying Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangying Kuang. Jiangying Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuang, Jiangying, Jian Chen, Kan Liu, et al.. (2025). Sacubitril/valsartan attenuates inflammation and myocardial fibrosis in Takotsubo-like cardiomyopathy. Journal of Molecular and Cellular Cardiology. 200. 24–39. 5 indexed citations

Kuang, Jiangying, Nana Huang, Jianchao Li, et al.. (2025). Shouhui Tongbian Capsule ameliorates obesity by enhancing energy consumption and promoting lipolysis via cAMP-PKA pathway. Phytomedicine. 138. 156375–156375. 2 indexed citations

Shang, Kun, et al.. (2025). Sex differences of neutrophil to high-density lipoprotein cholesterol ratio in predicting the severity of coronary lesions in acute coronary syndrome patients. Lipids in Health and Disease. 24(1). 54–54. 2 indexed citations

Kuang, Jiangying, et al.. (2024). Exosomal Hsp27 protein are associated with heart failure in STZ-induced type 1 diabetic rats. International Journal of Biological Macromolecules. 277(Pt 1). 133772–133772. 2 indexed citations

Shang, Kun, et al.. (2023). Hypertension and cystatin C account for sex differences in serum homocysteine levels in acute coronary syndrome subjects with normal serum creatinine. Journal of Health Population and Nutrition. 42(1). 81–81. 1 indexed citations

Li, Jianchao, Jiangying Kuang, Nana Huang, et al.. (2022). Si–Ni-SAN ameliorates obesity through AKT/AMPK/HSL pathway-mediated lipolysis: Network pharmacology and experimental validation. Journal of Ethnopharmacology. 302(Pt A). 115892–115892. 16 indexed citations

Kuang, Jiangying, Guijun Liu, Weijie Wu, et al.. (2022). Myostain is involved in ginsenoside Rb1-mediated anti-obesity. Pharmaceutical Biology. 60(1). 1106–1115. 6 indexed citations

Kuang, Jiangying, et al.. (2021). Reduced Insulin‐Like Growth Factor 1 Is Associated with Insulin Resistance in Obese Prepubertal Boys. BioMed Research International. 2021(1). 6680316–6680316. 8 indexed citations

Li, Xinyun, Tao Qin, Pengfei Zhang, et al.. (2021). Weak UVB Irradiation Promotes Macrophage M2 Polarization and Stabilizes Atherosclerosis. Journal of Cardiovascular Translational Research. 15(4). 855–864. 5 indexed citations

10.

Pu, Shiyun, Yanping Li, Qinhui Liu, et al.. (2021). Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis. Frontiers in Pharmacology. 12. 628583–628583. 17 indexed citations

11.

Xing, Xiaowei, Shuang Guo, Jiangying Kuang, et al.. (2021). Saxagliptin protects against diabetic nephropathy by inhibiting caspase 3/PARP‑1‑dependent nephrocyte apoptosis. Experimental and Therapeutic Medicine. 22(3). 990–990. 5 indexed citations

12.

Li, Changling, Bin Liu, Zhaoyang Wang, et al.. (2020). Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3. Journal of Molecular and Cellular Cardiology. 139. 98–112. 73 indexed citations

13.

Zhao, Tong, Chao Cheng, Juan Zhang, et al.. (2019). Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1. Biomedicine & Pharmacotherapy. 118. 109224–109224. 29 indexed citations

14.

Li, Hong, Jing Shen, Tong Wu, et al.. (2019). Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis. Frontiers in Pharmacology. 10. 548–548. 27 indexed citations

15.

Cheng, Shihai, Min Zou, Qinhui Liu, et al.. (2017). Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation. American Journal Of Pathology. 187(4). 808–818. 29 indexed citations

16.

He, Jinhan, Chong Xu, Jiangying Kuang, et al.. (2015). Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance. Metabolism. 64(7). 826–836. 33 indexed citations

17.

Pu, Shiyun, Ren Lin, Qinhui Liu, et al.. (2015). Loss of 5‐lipoxygenase activity protects mice against paracetamol‐induced liver toxicity. British Journal of Pharmacology. 173(1). 66–76. 39 indexed citations

18.

Kuang, Jiangying, et al.. (2014). Identification of insulin as a novel retinoic acid receptor‐related orphan receptor α target gene. FEBS Letters. 588(6). 1071–1079. 25 indexed citations

19.

Kuang, Jiangying, et al.. (2012). Association between fibroblast growth factor 7 and the risk of chronic obstructive pulmonary disease. Acta Pharmacologica Sinica. 33(8). 998–1003. 12 indexed citations

20.

Yuan, Yiming, et al.. (2012). Genetic Variations in ADIPOQ Gene Are Associated with Chronic Obstructive Pulmonary Disease. PLoS ONE. 7(11). e50848–e50848. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact